How will the price of Ceritinib change after medical insurance? Drug costs after medical insurance reimbursement

Ceritinib (Ceritinib), as a targeted therapy drug, has been officially launched in China and has been included in the medical insurance directory, which is an important benefit for patients who require long-term treatment. After being included in medical insurance, patients can enjoy the medical insurance reimbursement policy when purchasing ceritinib, which significantly reduces the burden of medication and improves drug accessibility and usage.

Specifically, after medical insurance reimbursement, the patient's out-of-pocket expenses will be significantly reduced, but the specific reimbursement ratio and out-of-pocket amount will vary depending on the medical insurance policies of different regions. Generally speaking, the reimbursement ratio for anti-cancer drugs in the medical insurance catalog is higher, and the actual drug costs paid by patients will be much lower than when they are not included in medical insurance. Patients should consult the hospital pharmacy in detail when purchasing to learn about local medical insurance reimbursement policies and actual prices.

Although the price of domestic original ceritinib is relatively high, the addition of medical insurance has effectively alleviated the financial pressure on patients. At the same time, there are also generic drugs from Laos on the market, the price is only more than 1,000 yuan, and the drug ingredients are basically the same as the domestic original drugs, providing patients with more economic choices. This kind of generic drug has certain appeal to patients with limited financial conditions or who want to reduce the cost of treatment.

In short, after ceritinib was included in medical insurance, patients' drug costs dropped significantly, greatly improving the economic burden of treatment. When patients choose medications, they can reasonably arrange treatment plans based on medical insurance policies and drug sources. It is recommended that patients actively communicate with doctors and pharmacies to ensure they receive the optimal medication plan and financial support.

Reference materials:https://www.novartis.com/our-products/pipeline/ceritinib